美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Tevogen Bio Holdings Inc.

0.0472

-0.0067-12.43%

成交量：40.19萬

成交額：1.85萬

市值：- -

市盈率：- -

高：0.0569

開：0.0529

低：0.0420

收：0.0539

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Tevogen Bio Holdings Inc.

交易所：

NASDAQ

成立時間：

- -

員工人數：

- -

公司地址：

- -

官網：

http://semperparatusspac.com

郵編：

- -

電話：

- -

傳真：

- -

簡介：

Tevogen Bio Holdings Inc.於2021年4月21日在開曼群島註冊成立，后合併重組為特拉華州公司。Tevogen Bio是一家臨床階段的專業免疫療法公司，利用自然界最強大的免疫武器之一—CD8 +細胞毒性T淋巴細胞，開發現成的、未經基因改造的精準T細胞療法，用於治療傳染病、癌症和神經系統疾病，旨在解決大量患者群體的重大未滿足需求。

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TVGNW/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TVGNW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGNW\",,,,,undefined,":{"symbol":"TVGNW","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings Inc.","latestPrice":0.0472,"timestamp":1743537600000,"preClose":0.0539,"halted":0,"volume":401884,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未開盤","change":-0.0067,"latestTime":"04-01 16:00:00 EDT","open":0.0529,"high":0.0569,"low":0.042,"amount":18525.306425,"amplitude":0.276438,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1743580800000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0539,"volumeRatio":1.366266},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TVGNW\",,,,,undefined,":{"symbol":"TVGNW","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.366266,"shares":0,"dividePrice":0,"high":0.0569,"amplitude":0.276438,"preClose":0.0539,"low":0.042,"week52Low":0.0099,"pbRate":"--","week52High":0.1499,"institutionHeld":0,"latestPrice":0.0472,"eps":0,"divideRate":0,"volume":401884,"delay":0,"ttmEps":0,"open":0.0529,"prevYearClose":0.054,"prevWeekClose":0.0579,"prevMonthClose":0.0539,"prevQuarterClose":0.0539,"fiveDayClose":0.0579,"twentyDayClose":0.0724,"sixtyDayClose":0.06},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://semperparatusspac.com","stockEarnings":[{"period":"1week","weight":-0.1552},{"period":"1month","weight":-0.1943},{"period":"3month","weight":-0.0019},{"period":"6month","weight":3.2441},{"period":"1year","weight":-0.3467},{"period":"ytd","weight":-0.0019}],"compareEarnings":[{"period":"1week","weight":-0.0256},{"period":"1month","weight":-0.0586},{"period":"3month","weight":-0.0455},{"period":"6month","weight":-0.0166},{"period":"1year","weight":0.0694},{"period":"ytd","weight":-0.0455}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Tevogen Bio Holdings Inc.於2021年4月21日在開曼群島註冊成立，后合併重組為特拉華州公司。Tevogen Bio是一家臨床階段的專業免疫療法公司，利用自然界最強大的免疫武器之一—CD8 +細胞毒性T淋巴細胞，開發現成的、未經基因改造的精準T細胞療法，用於治療傳染病、癌症和神經系統疾病，旨在解決大量患者群體的重大未滿足需求。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":1.578518},{"month":2,"riseRate":0.25,"avgChangeRate":0.208292},{"month":3,"riseRate":0.5,"avgChangeRate":-0.000591},{"month":4,"riseRate":0,"avgChangeRate":-0.282545},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.106184},{"month":6,"riseRate":0,"avgChangeRate":-0.176798},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.059726},{"month":8,"riseRate":0.333333,"avgChangeRate":0.1125},{"month":9,"riseRate":0,"avgChangeRate":-0.256349},{"month":10,"riseRate":0.333333,"avgChangeRate":1.818294},{"month":11,"riseRate":0,"avgChangeRate":-0.508558},{"month":12,"riseRate":0.333333,"avgChangeRate":0.083737}],"exchange":"NASDAQ","name":"Tevogen Bio Holdings Inc.","nameEN":"Tevogen Bio Holdings Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"TVGNW\",market:\"US\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TVGNW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-02-15","symbol":"TVGNW","reason":null,"defaultRemindTime":1708007400000,"announcedDate":"2024-02-14","type":"delisting","dateTimestamp":1707973200000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TVGNW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TVGNW\",market:\"US\",delay:false,,,undefined,":{}}}